Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Bcrp). Showing records 1 – 30 of 38 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

▼ Search Limiters


University of Rhode Island

1. Bell, Samuel D. Understanding Pregnancy Centered Medications: Characterizing the Interactions of a Series of Sulfonylurea Analogs and the ATP Binding Cassette Transporter Proteins, P-Glycoprotein and Breast Cancer Resistance Protein.

Degree: 2017, University of Rhode Island

 The oral hypoglycemic agent Glyburide has been shown to be actively transported from various biological tissues though a pronounced interaction with the ATP binding cassette… (more)

Subjects/Keywords: ABC; BCRP; Glyburide; Pgp; Transporters

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bell, S. D. (2017). Understanding Pregnancy Centered Medications: Characterizing the Interactions of a Series of Sulfonylurea Analogs and the ATP Binding Cassette Transporter Proteins, P-Glycoprotein and Breast Cancer Resistance Protein. (Doctoral Dissertation). University of Rhode Island. Retrieved from https://digitalcommons.uri.edu/oa_diss/747

Chicago Manual of Style (16th Edition):

Bell, Samuel D. “Understanding Pregnancy Centered Medications: Characterizing the Interactions of a Series of Sulfonylurea Analogs and the ATP Binding Cassette Transporter Proteins, P-Glycoprotein and Breast Cancer Resistance Protein.” 2017. Doctoral Dissertation, University of Rhode Island. Accessed October 16, 2019. https://digitalcommons.uri.edu/oa_diss/747.

MLA Handbook (7th Edition):

Bell, Samuel D. “Understanding Pregnancy Centered Medications: Characterizing the Interactions of a Series of Sulfonylurea Analogs and the ATP Binding Cassette Transporter Proteins, P-Glycoprotein and Breast Cancer Resistance Protein.” 2017. Web. 16 Oct 2019.

Vancouver:

Bell SD. Understanding Pregnancy Centered Medications: Characterizing the Interactions of a Series of Sulfonylurea Analogs and the ATP Binding Cassette Transporter Proteins, P-Glycoprotein and Breast Cancer Resistance Protein. [Internet] [Doctoral dissertation]. University of Rhode Island; 2017. [cited 2019 Oct 16]. Available from: https://digitalcommons.uri.edu/oa_diss/747.

Council of Science Editors:

Bell SD. Understanding Pregnancy Centered Medications: Characterizing the Interactions of a Series of Sulfonylurea Analogs and the ATP Binding Cassette Transporter Proteins, P-Glycoprotein and Breast Cancer Resistance Protein. [Doctoral Dissertation]. University of Rhode Island; 2017. Available from: https://digitalcommons.uri.edu/oa_diss/747


University of Vienna

2. Elghalban, Ahmed. Probing inhibitory potential of aryl-methoxy derivates on ABCG2 with a fluorescent substrate accumulation assay.

Degree: 2017, University of Vienna

Die Superfamilie der ATP-Bindungskassette (ABC) ist eine der größten Proteinfamilien, da ihre Mitglieder in prokaryotischen und eukaryotischen Organismen ubiquitär exprimiert werden. Es handelt sich um… (more)

Subjects/Keywords: 44.40 Pharmazie, Pharmazeutika; Krebs / BCRP / Arzneimittelwechselwirkung

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Elghalban, A. (2017). Probing inhibitory potential of aryl-methoxy derivates on ABCG2 with a fluorescent substrate accumulation assay. (Thesis). University of Vienna. Retrieved from http://othes.univie.ac.at/46284/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Elghalban, Ahmed. “Probing inhibitory potential of aryl-methoxy derivates on ABCG2 with a fluorescent substrate accumulation assay.” 2017. Thesis, University of Vienna. Accessed October 16, 2019. http://othes.univie.ac.at/46284/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Elghalban, Ahmed. “Probing inhibitory potential of aryl-methoxy derivates on ABCG2 with a fluorescent substrate accumulation assay.” 2017. Web. 16 Oct 2019.

Vancouver:

Elghalban A. Probing inhibitory potential of aryl-methoxy derivates on ABCG2 with a fluorescent substrate accumulation assay. [Internet] [Thesis]. University of Vienna; 2017. [cited 2019 Oct 16]. Available from: http://othes.univie.ac.at/46284/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Elghalban A. Probing inhibitory potential of aryl-methoxy derivates on ABCG2 with a fluorescent substrate accumulation assay. [Thesis]. University of Vienna; 2017. Available from: http://othes.univie.ac.at/46284/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université de Grenoble

3. Genoux, Estelle. Dérivés de flavonoïdes et de vérapamil comme ligands des transporteurs MRP1 et ABCG2 : de la conception à l'activité anticancéreuse : Derivatives of flavonoids and verapamil as ligands of MRP1 and ABCG2 transporters : from design to anticancer activity.

Degree: Docteur es, Chimie biologie, 2011, Université de Grenoble

La résistance aux agents chimiothérapeutiques (Multidrug Resistance ou MDR) est caractérisée par la surexpression de différentes protéines membranaires de type ABC, parmi lesquelles, MRP1 et… (more)

Subjects/Keywords: Flavonoïdes; Pharmacomodulation; Anticancéreux; MRP1; BCRP; Flavonoids; Pharmacomodulation; Anticancer agents; Modulators; MRP1; BCRP; 540; 570

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Genoux, E. (2011). Dérivés de flavonoïdes et de vérapamil comme ligands des transporteurs MRP1 et ABCG2 : de la conception à l'activité anticancéreuse : Derivatives of flavonoids and verapamil as ligands of MRP1 and ABCG2 transporters : from design to anticancer activity. (Doctoral Dissertation). Université de Grenoble. Retrieved from http://www.theses.fr/2011GRENV015

Chicago Manual of Style (16th Edition):

Genoux, Estelle. “Dérivés de flavonoïdes et de vérapamil comme ligands des transporteurs MRP1 et ABCG2 : de la conception à l'activité anticancéreuse : Derivatives of flavonoids and verapamil as ligands of MRP1 and ABCG2 transporters : from design to anticancer activity.” 2011. Doctoral Dissertation, Université de Grenoble. Accessed October 16, 2019. http://www.theses.fr/2011GRENV015.

MLA Handbook (7th Edition):

Genoux, Estelle. “Dérivés de flavonoïdes et de vérapamil comme ligands des transporteurs MRP1 et ABCG2 : de la conception à l'activité anticancéreuse : Derivatives of flavonoids and verapamil as ligands of MRP1 and ABCG2 transporters : from design to anticancer activity.” 2011. Web. 16 Oct 2019.

Vancouver:

Genoux E. Dérivés de flavonoïdes et de vérapamil comme ligands des transporteurs MRP1 et ABCG2 : de la conception à l'activité anticancéreuse : Derivatives of flavonoids and verapamil as ligands of MRP1 and ABCG2 transporters : from design to anticancer activity. [Internet] [Doctoral dissertation]. Université de Grenoble; 2011. [cited 2019 Oct 16]. Available from: http://www.theses.fr/2011GRENV015.

Council of Science Editors:

Genoux E. Dérivés de flavonoïdes et de vérapamil comme ligands des transporteurs MRP1 et ABCG2 : de la conception à l'activité anticancéreuse : Derivatives of flavonoids and verapamil as ligands of MRP1 and ABCG2 transporters : from design to anticancer activity. [Doctoral Dissertation]. Université de Grenoble; 2011. Available from: http://www.theses.fr/2011GRENV015


University of Kentucky

4. Adane, Eyob Debebe. LACTONE-CARBOXYLATE INTERCONVERSION AS A DETERMINANT OF THE CLEARANCE AND ORAL BIOAVAILABILTY OF THE LIPOPHILIC CAMPTOTHECIN ANALOG AR-67.

Degree: 2010, University of Kentucky

 The third generation camptothecin analog, AR-67, is undergoing early phase clinical trials as a chemotherapeutic agent. Like all camptothecins it undergoes pH dependent reversible hydrolysis… (more)

Subjects/Keywords: AR-67; interconversion; lactone; carboxylate; P-gp; BCRP/Bcrp; OATP/Oatp; inverse Gaussian; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Adane, E. D. (2010). LACTONE-CARBOXYLATE INTERCONVERSION AS A DETERMINANT OF THE CLEARANCE AND ORAL BIOAVAILABILTY OF THE LIPOPHILIC CAMPTOTHECIN ANALOG AR-67. (Doctoral Dissertation). University of Kentucky. Retrieved from https://uknowledge.uky.edu/gradschool_diss/47

Chicago Manual of Style (16th Edition):

Adane, Eyob Debebe. “LACTONE-CARBOXYLATE INTERCONVERSION AS A DETERMINANT OF THE CLEARANCE AND ORAL BIOAVAILABILTY OF THE LIPOPHILIC CAMPTOTHECIN ANALOG AR-67.” 2010. Doctoral Dissertation, University of Kentucky. Accessed October 16, 2019. https://uknowledge.uky.edu/gradschool_diss/47.

MLA Handbook (7th Edition):

Adane, Eyob Debebe. “LACTONE-CARBOXYLATE INTERCONVERSION AS A DETERMINANT OF THE CLEARANCE AND ORAL BIOAVAILABILTY OF THE LIPOPHILIC CAMPTOTHECIN ANALOG AR-67.” 2010. Web. 16 Oct 2019.

Vancouver:

Adane ED. LACTONE-CARBOXYLATE INTERCONVERSION AS A DETERMINANT OF THE CLEARANCE AND ORAL BIOAVAILABILTY OF THE LIPOPHILIC CAMPTOTHECIN ANALOG AR-67. [Internet] [Doctoral dissertation]. University of Kentucky; 2010. [cited 2019 Oct 16]. Available from: https://uknowledge.uky.edu/gradschool_diss/47.

Council of Science Editors:

Adane ED. LACTONE-CARBOXYLATE INTERCONVERSION AS A DETERMINANT OF THE CLEARANCE AND ORAL BIOAVAILABILTY OF THE LIPOPHILIC CAMPTOTHECIN ANALOG AR-67. [Doctoral Dissertation]. University of Kentucky; 2010. Available from: https://uknowledge.uky.edu/gradschool_diss/47


University of Debrecen

5. Téglási, Annamária. A sejtmembrán koleszterin tartalmának hatása a P-glikoprotein és az ABCG2 fehérje működésére .

Degree: DE – TEK – Természettudományi és Technológiai Kar – Biológiai és Ökológiai Intézet, 2011, University of Debrecen

 A P-glikoprotein és ABCG2 fehérje működésének modulálása a membrán lipidösszetételének befolyásolásával: Az ABCB1 (MDR1/P-glikoprotein) és az ABCG2 (BCRP/ABCP/MXR) transzmembrán fehérjék az ABC (ATP-Binding Casette) transzporter… (more)

Subjects/Keywords: P-glikoprotein; multidrog rezisztencia; ABCG2; koleszterin; MDR1; BCRP

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Téglási, A. (2011). A sejtmembrán koleszterin tartalmának hatása a P-glikoprotein és az ABCG2 fehérje működésére . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/108312

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Téglási, Annamária. “A sejtmembrán koleszterin tartalmának hatása a P-glikoprotein és az ABCG2 fehérje működésére .” 2011. Thesis, University of Debrecen. Accessed October 16, 2019. http://hdl.handle.net/2437/108312.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Téglási, Annamária. “A sejtmembrán koleszterin tartalmának hatása a P-glikoprotein és az ABCG2 fehérje működésére .” 2011. Web. 16 Oct 2019.

Vancouver:

Téglási A. A sejtmembrán koleszterin tartalmának hatása a P-glikoprotein és az ABCG2 fehérje működésére . [Internet] [Thesis]. University of Debrecen; 2011. [cited 2019 Oct 16]. Available from: http://hdl.handle.net/2437/108312.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Téglási A. A sejtmembrán koleszterin tartalmának hatása a P-glikoprotein és az ABCG2 fehérje működésére . [Thesis]. University of Debrecen; 2011. Available from: http://hdl.handle.net/2437/108312

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Vienna

6. Visvader, Lene. Synthese fluorsubstituierter Propafenonanaloga.

Degree: 2017, University of Vienna

Viele Menschen weltweit leiden an Krebs, daher haben Wissenschaftler verschiedene Methoden entwickelt um diese Krankheit zu bekämpfen. Eine Behandlung im Kampf gegen Krebs ist der… (more)

Subjects/Keywords: 44.42 Pharmazeutische Chemie; Propafenon / P-Glykoprotein / BCRP / Fluor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Visvader, L. (2017). Synthese fluorsubstituierter Propafenonanaloga. (Thesis). University of Vienna. Retrieved from http://othes.univie.ac.at/46593/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Visvader, Lene. “Synthese fluorsubstituierter Propafenonanaloga.” 2017. Thesis, University of Vienna. Accessed October 16, 2019. http://othes.univie.ac.at/46593/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Visvader, Lene. “Synthese fluorsubstituierter Propafenonanaloga.” 2017. Web. 16 Oct 2019.

Vancouver:

Visvader L. Synthese fluorsubstituierter Propafenonanaloga. [Internet] [Thesis]. University of Vienna; 2017. [cited 2019 Oct 16]. Available from: http://othes.univie.ac.at/46593/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Visvader L. Synthese fluorsubstituierter Propafenonanaloga. [Thesis]. University of Vienna; 2017. Available from: http://othes.univie.ac.at/46593/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Helsinki

7. Leppänen, Riikka. Farmakokineettinen mallinnus kuljettajaproteiinien polymorfioiden merkityksen arvioinnissa.

Degree: Farmaceutiska fakulteten, 2017, University of Helsinki

The effect of genes on drug response is studied in the field of pharmacogenetics. Genetic polymorphism occurs in several genes that code drug metabolizing enzymes… (more)

Subjects/Keywords: OATP1B1; BCRP; pharmacokinetic modelling; pharmacogenetics; rosuvastatin; farmakokineettinen mallinnus; farmakogenetiikka; rosuvastatiini; Biofarmaci; Biopharmacy; Biofarmasia; OATP1B1; BCRP; pharmacokinetic modelling; pharmacogenetics; rosuvastatin; farmakokineettinen mallinnus; farmakogenetiikka; rosuvastatiini

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leppänen, R. (2017). Farmakokineettinen mallinnus kuljettajaproteiinien polymorfioiden merkityksen arvioinnissa. (Masters Thesis). University of Helsinki. Retrieved from http://hdl.handle.net/10138/199521

Chicago Manual of Style (16th Edition):

Leppänen, Riikka. “Farmakokineettinen mallinnus kuljettajaproteiinien polymorfioiden merkityksen arvioinnissa.” 2017. Masters Thesis, University of Helsinki. Accessed October 16, 2019. http://hdl.handle.net/10138/199521.

MLA Handbook (7th Edition):

Leppänen, Riikka. “Farmakokineettinen mallinnus kuljettajaproteiinien polymorfioiden merkityksen arvioinnissa.” 2017. Web. 16 Oct 2019.

Vancouver:

Leppänen R. Farmakokineettinen mallinnus kuljettajaproteiinien polymorfioiden merkityksen arvioinnissa. [Internet] [Masters thesis]. University of Helsinki; 2017. [cited 2019 Oct 16]. Available from: http://hdl.handle.net/10138/199521.

Council of Science Editors:

Leppänen R. Farmakokineettinen mallinnus kuljettajaproteiinien polymorfioiden merkityksen arvioinnissa. [Masters Thesis]. University of Helsinki; 2017. Available from: http://hdl.handle.net/10138/199521

8. 杉山, 崇; スギヤマ, タカシ. ABCトランスポーターBCRPの小胞体膜タンパク質Derlin-1による品質管理 : ABC トランスポーター BCRP ノ ショウホウタイ マク タンパクシツ Derlin-1 ニ ヨル ヒンシツ カンリ; Glycosylation-dependent quality control of ABC transporter BCRP by the ER membrane protein, Derlin-1.

Degree: Kumamoto University / 熊本大学

本研究では,糖鎖付加状態がBCRPの野生型と変異型を区別するチェックポイントの一端であるという仮説に基づき,野生型BCRPと糖鎖付加不全変異型N596Q BCRPに対して異なった発現変化を起こすような因子をスクリーニングした.その結果,ER膜タンパク質であるDerlin-1が,BCRPの糖鎖付加状態に応じて異なる発現変化を起こすことを見出した.

Subjects/Keywords: BCRP; 小胞体; Derlin-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

杉山, 崇; スギヤマ, . (n.d.). ABCトランスポーターBCRPの小胞体膜タンパク質Derlin-1による品質管理 : ABC トランスポーター BCRP ノ ショウホウタイ マク タンパクシツ Derlin-1 ニ ヨル ヒンシツ カンリ; Glycosylation-dependent quality control of ABC transporter BCRP by the ER membrane protein, Derlin-1. (Thesis). Kumamoto University / 熊本大学. Retrieved from http://hdl.handle.net/2298/22142

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

杉山, 崇; スギヤマ, タカシ. “ABCトランスポーターBCRPの小胞体膜タンパク質Derlin-1による品質管理 : ABC トランスポーター BCRP ノ ショウホウタイ マク タンパクシツ Derlin-1 ニ ヨル ヒンシツ カンリ; Glycosylation-dependent quality control of ABC transporter BCRP by the ER membrane protein, Derlin-1.” Thesis, Kumamoto University / 熊本大学. Accessed October 16, 2019. http://hdl.handle.net/2298/22142.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

杉山, 崇; スギヤマ, タカシ. “ABCトランスポーターBCRPの小胞体膜タンパク質Derlin-1による品質管理 : ABC トランスポーター BCRP ノ ショウホウタイ マク タンパクシツ Derlin-1 ニ ヨル ヒンシツ カンリ; Glycosylation-dependent quality control of ABC transporter BCRP by the ER membrane protein, Derlin-1.” Web. 16 Oct 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

杉山, 崇; スギヤマ . ABCトランスポーターBCRPの小胞体膜タンパク質Derlin-1による品質管理 : ABC トランスポーター BCRP ノ ショウホウタイ マク タンパクシツ Derlin-1 ニ ヨル ヒンシツ カンリ; Glycosylation-dependent quality control of ABC transporter BCRP by the ER membrane protein, Derlin-1. [Internet] [Thesis]. Kumamoto University / 熊本大学; [cited 2019 Oct 16]. Available from: http://hdl.handle.net/2298/22142.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

杉山, 崇; スギヤマ . ABCトランスポーターBCRPの小胞体膜タンパク質Derlin-1による品質管理 : ABC トランスポーター BCRP ノ ショウホウタイ マク タンパクシツ Derlin-1 ニ ヨル ヒンシツ カンリ; Glycosylation-dependent quality control of ABC transporter BCRP by the ER membrane protein, Derlin-1. [Thesis]. Kumamoto University / 熊本大学; Available from: http://hdl.handle.net/2298/22142

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Ottawa

9. Rainey, Jenna. The Regulation of Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp) and Breast Cancer Resistance Protein (BCRP) in the Human Placenta .

Degree: 2011, University of Ottawa

 Multidrug resistance phosphoglycoprotein (MDR1/P-gp) and breast cancer resistance protein (BCRP) were first isolated in chemoresistant cancer cells and have since been found in a variety… (more)

Subjects/Keywords: Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp); Breast Cancer Resistance Protein (BCRP); Human Placenta

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rainey, J. (2011). The Regulation of Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp) and Breast Cancer Resistance Protein (BCRP) in the Human Placenta . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/19961

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Rainey, Jenna. “The Regulation of Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp) and Breast Cancer Resistance Protein (BCRP) in the Human Placenta .” 2011. Thesis, University of Ottawa. Accessed October 16, 2019. http://hdl.handle.net/10393/19961.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Rainey, Jenna. “The Regulation of Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp) and Breast Cancer Resistance Protein (BCRP) in the Human Placenta .” 2011. Web. 16 Oct 2019.

Vancouver:

Rainey J. The Regulation of Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp) and Breast Cancer Resistance Protein (BCRP) in the Human Placenta . [Internet] [Thesis]. University of Ottawa; 2011. [cited 2019 Oct 16]. Available from: http://hdl.handle.net/10393/19961.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Rainey J. The Regulation of Multidrug Resistance Phosphoglycoprotein (MDR1/P-gp) and Breast Cancer Resistance Protein (BCRP) in the Human Placenta . [Thesis]. University of Ottawa; 2011. Available from: http://hdl.handle.net/10393/19961

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of South Florida

10. Blake, Lynn Dong. Antimalarial Exoerythrocytic Stage Drug Discovery and Resistance Studies.

Degree: 2016, University of South Florida

 Malaria is a devastating global health issue that affects approximately 200 million people yearly and over half a million deaths are caused by this parasitic… (more)

Subjects/Keywords: Malaria; Plasmodium; liver; drug assay; menoctone; BCRP; genetics; Medicine and Health Sciences; Microbiology; Parasitology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Blake, L. D. (2016). Antimalarial Exoerythrocytic Stage Drug Discovery and Resistance Studies. (Thesis). University of South Florida. Retrieved from https://scholarcommons.usf.edu/etd/6182

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Blake, Lynn Dong. “Antimalarial Exoerythrocytic Stage Drug Discovery and Resistance Studies.” 2016. Thesis, University of South Florida. Accessed October 16, 2019. https://scholarcommons.usf.edu/etd/6182.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Blake, Lynn Dong. “Antimalarial Exoerythrocytic Stage Drug Discovery and Resistance Studies.” 2016. Web. 16 Oct 2019.

Vancouver:

Blake LD. Antimalarial Exoerythrocytic Stage Drug Discovery and Resistance Studies. [Internet] [Thesis]. University of South Florida; 2016. [cited 2019 Oct 16]. Available from: https://scholarcommons.usf.edu/etd/6182.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Blake LD. Antimalarial Exoerythrocytic Stage Drug Discovery and Resistance Studies. [Thesis]. University of South Florida; 2016. Available from: https://scholarcommons.usf.edu/etd/6182

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

11. Agarwal, Sagar Suresh. Improving delivery of molecularly targeted agents to glioma.

Degree: PhD, Pharmaceutics, 2011, University of Minnesota

 Treatment of glioblastoma multiforme is at a crossroads. Promising new molecularly-targeted agents have failed to show any significant clinical benefit. Treatment is particularly challenging since… (more)

Subjects/Keywords: BCRP; Blood Brain Barrier; Glioblastoma; Glioma; Molecularly Targeted Agents; P-glycoprotein; Pharmaceutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Agarwal, S. S. (2011). Improving delivery of molecularly targeted agents to glioma. (Doctoral Dissertation). University of Minnesota. Retrieved from http://purl.umn.edu/109325

Chicago Manual of Style (16th Edition):

Agarwal, Sagar Suresh. “Improving delivery of molecularly targeted agents to glioma.” 2011. Doctoral Dissertation, University of Minnesota. Accessed October 16, 2019. http://purl.umn.edu/109325.

MLA Handbook (7th Edition):

Agarwal, Sagar Suresh. “Improving delivery of molecularly targeted agents to glioma.” 2011. Web. 16 Oct 2019.

Vancouver:

Agarwal SS. Improving delivery of molecularly targeted agents to glioma. [Internet] [Doctoral dissertation]. University of Minnesota; 2011. [cited 2019 Oct 16]. Available from: http://purl.umn.edu/109325.

Council of Science Editors:

Agarwal SS. Improving delivery of molecularly targeted agents to glioma. [Doctoral Dissertation]. University of Minnesota; 2011. Available from: http://purl.umn.edu/109325


University of Kansas

12. Mitra, Pallabi. ROLES OF SULFOTRANSFERASE ENZYMES IN TRANS-PLACENTAL DISPOSITION.

Degree: PhD, Pharmaceutical Chemistry, 2009, University of Kansas

 The trophoblast cell layer constitutes the rate-determining barrier for trans-placental transfer. Several isoforms of the sulfotransferase enzymes are functional in placenta but there is only… (more)

Subjects/Keywords: Pharmaceutical chemistry; Bisphenol a; Breast cancer resistance protein (bcrp); Multidrug resistance-associated protein (mrp); Placenta; Sulfotransferase enzymes; Trophoblast

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mitra, P. (2009). ROLES OF SULFOTRANSFERASE ENZYMES IN TRANS-PLACENTAL DISPOSITION. (Doctoral Dissertation). University of Kansas. Retrieved from http://hdl.handle.net/1808/6185

Chicago Manual of Style (16th Edition):

Mitra, Pallabi. “ROLES OF SULFOTRANSFERASE ENZYMES IN TRANS-PLACENTAL DISPOSITION.” 2009. Doctoral Dissertation, University of Kansas. Accessed October 16, 2019. http://hdl.handle.net/1808/6185.

MLA Handbook (7th Edition):

Mitra, Pallabi. “ROLES OF SULFOTRANSFERASE ENZYMES IN TRANS-PLACENTAL DISPOSITION.” 2009. Web. 16 Oct 2019.

Vancouver:

Mitra P. ROLES OF SULFOTRANSFERASE ENZYMES IN TRANS-PLACENTAL DISPOSITION. [Internet] [Doctoral dissertation]. University of Kansas; 2009. [cited 2019 Oct 16]. Available from: http://hdl.handle.net/1808/6185.

Council of Science Editors:

Mitra P. ROLES OF SULFOTRANSFERASE ENZYMES IN TRANS-PLACENTAL DISPOSITION. [Doctoral Dissertation]. University of Kansas; 2009. Available from: http://hdl.handle.net/1808/6185


Univerzitet u Beogradu

13. Stojšić, Jelena M., 1960-. Prediktivni značaj PI3K/Akt signalnog puta i transportnih pumpi uključenih u razvoj rezistencije na lekove kod bolesnika sa nemikrocelularnim karcinomom pluća.

Degree: Medicinski fakultet, 2016, Univerzitet u Beogradu

Medicina / Medicine

Uvod: Karcinom pluća je najčešći uzrok smrti od maligniteta globalno. Oko 80% svih karcinoma pluća su nesitnoćelijski karcinomi (NSCLC) kod kojih preovladavaju… (more)

Subjects/Keywords: non-small cell lung cancer; neoadjuvant chemotherapy; signal pathways; LOH PTEN; PTEN; pERK; pAKT; Pg-p; MRP1; BCRP

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stojšić, Jelena M., 1. (2016). Prediktivni značaj PI3K/Akt signalnog puta i transportnih pumpi uključenih u razvoj rezistencije na lekove kod bolesnika sa nemikrocelularnim karcinomom pluća. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:13383/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Stojšić, Jelena M., 1960-. “Prediktivni značaj PI3K/Akt signalnog puta i transportnih pumpi uključenih u razvoj rezistencije na lekove kod bolesnika sa nemikrocelularnim karcinomom pluća.” 2016. Thesis, Univerzitet u Beogradu. Accessed October 16, 2019. https://fedorabg.bg.ac.rs/fedora/get/o:13383/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Stojšić, Jelena M., 1960-. “Prediktivni značaj PI3K/Akt signalnog puta i transportnih pumpi uključenih u razvoj rezistencije na lekove kod bolesnika sa nemikrocelularnim karcinomom pluća.” 2016. Web. 16 Oct 2019.

Vancouver:

Stojšić, Jelena M. 1. Prediktivni značaj PI3K/Akt signalnog puta i transportnih pumpi uključenih u razvoj rezistencije na lekove kod bolesnika sa nemikrocelularnim karcinomom pluća. [Internet] [Thesis]. Univerzitet u Beogradu; 2016. [cited 2019 Oct 16]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:13383/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Stojšić, Jelena M. 1. Prediktivni značaj PI3K/Akt signalnog puta i transportnih pumpi uključenih u razvoj rezistencije na lekove kod bolesnika sa nemikrocelularnim karcinomom pluća. [Thesis]. Univerzitet u Beogradu; 2016. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:13383/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universiteit Utrecht

14. Vries, N.A. de. Preclinical models to study the impact of the blood-brain barrier in brain tumor chemotherapy.

Degree: 2009, Universiteit Utrecht

 High-grade gliomas, in particular Glioblastoma Multiforme (GBM), are the most common primary brain tumors in adults and among the deadliest of human cancers. Their location… (more)

Subjects/Keywords: Farmacie; blood-brain barrier; brain cancer; chemotherapy; drug transporters; malignant glioma; high-grade glioma mouse models; P-gp; BCRP

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vries, N. A. d. (2009). Preclinical models to study the impact of the blood-brain barrier in brain tumor chemotherapy. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/33441

Chicago Manual of Style (16th Edition):

Vries, N A de. “Preclinical models to study the impact of the blood-brain barrier in brain tumor chemotherapy.” 2009. Doctoral Dissertation, Universiteit Utrecht. Accessed October 16, 2019. http://dspace.library.uu.nl:8080/handle/1874/33441.

MLA Handbook (7th Edition):

Vries, N A de. “Preclinical models to study the impact of the blood-brain barrier in brain tumor chemotherapy.” 2009. Web. 16 Oct 2019.

Vancouver:

Vries NAd. Preclinical models to study the impact of the blood-brain barrier in brain tumor chemotherapy. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2009. [cited 2019 Oct 16]. Available from: http://dspace.library.uu.nl:8080/handle/1874/33441.

Council of Science Editors:

Vries NAd. Preclinical models to study the impact of the blood-brain barrier in brain tumor chemotherapy. [Doctoral Dissertation]. Universiteit Utrecht; 2009. Available from: http://dspace.library.uu.nl:8080/handle/1874/33441

15. Candela, Pietra. Transcytose à travers la barrière hémato-encéphalique : étude in vitro du transport des lipoproteines de basse densité et du peptide ß-amyloïde : Transcytosis through the blood brain barrier : in vitro studies of the transport of low density lipoprotein and ß-amyloid peptide.

Degree: Docteur es, Sciences de la Vie, 2010, Université d'Artois

La Barrière Hémato-Encéphalique (BHE) est une interface localisée au niveau des cellules endothéliales des capillaires cérébraux (CECs). Elle présente des caractéristiques structurales et métaboliques spécifiques… (more)

Subjects/Keywords: Barrière hémato-encéphalique; Transcytose; Cavéoles; Maladie d'Alzheimer; Peptide ß amyloïde; Rage; P-gp; Bcrp; In vitro

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Candela, P. (2010). Transcytose à travers la barrière hémato-encéphalique : étude in vitro du transport des lipoproteines de basse densité et du peptide ß-amyloïde : Transcytosis through the blood brain barrier : in vitro studies of the transport of low density lipoprotein and ß-amyloid peptide. (Doctoral Dissertation). Université d'Artois. Retrieved from http://www.theses.fr/2010ARTO0404

Chicago Manual of Style (16th Edition):

Candela, Pietra. “Transcytose à travers la barrière hémato-encéphalique : étude in vitro du transport des lipoproteines de basse densité et du peptide ß-amyloïde : Transcytosis through the blood brain barrier : in vitro studies of the transport of low density lipoprotein and ß-amyloid peptide.” 2010. Doctoral Dissertation, Université d'Artois. Accessed October 16, 2019. http://www.theses.fr/2010ARTO0404.

MLA Handbook (7th Edition):

Candela, Pietra. “Transcytose à travers la barrière hémato-encéphalique : étude in vitro du transport des lipoproteines de basse densité et du peptide ß-amyloïde : Transcytosis through the blood brain barrier : in vitro studies of the transport of low density lipoprotein and ß-amyloid peptide.” 2010. Web. 16 Oct 2019.

Vancouver:

Candela P. Transcytose à travers la barrière hémato-encéphalique : étude in vitro du transport des lipoproteines de basse densité et du peptide ß-amyloïde : Transcytosis through the blood brain barrier : in vitro studies of the transport of low density lipoprotein and ß-amyloid peptide. [Internet] [Doctoral dissertation]. Université d'Artois; 2010. [cited 2019 Oct 16]. Available from: http://www.theses.fr/2010ARTO0404.

Council of Science Editors:

Candela P. Transcytose à travers la barrière hémato-encéphalique : étude in vitro du transport des lipoproteines de basse densité et du peptide ß-amyloïde : Transcytosis through the blood brain barrier : in vitro studies of the transport of low density lipoprotein and ß-amyloid peptide. [Doctoral Dissertation]. Université d'Artois; 2010. Available from: http://www.theses.fr/2010ARTO0404


Univerzitet u Beogradu

16. Nedeljković, Milica D., 1984-. Molekularno profilisanje i karakterizacija trostruko negativnih i hormonski zavisnih tumora dojke.

Degree: Biološki fakultet, 2019, Univerzitet u Beogradu

Biologija - Molekularna biologija tumora / Biology - Tumor molecular biology

Karcinom dojke je i klinički i genetički heterogeno oboljenje sa varijabilnim odgovorom na terapiju.… (more)

Subjects/Keywords: CCND1; c-MYC; FGFR1; EGFR; copy number gain; triple negative breast cancer; hormone dependant breast cancer; BCRP; MRP1; chemotherapy resistance

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nedeljković, Milica D., 1. (2019). Molekularno profilisanje i karakterizacija trostruko negativnih i hormonski zavisnih tumora dojke. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:19393/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Nedeljković, Milica D., 1984-. “Molekularno profilisanje i karakterizacija trostruko negativnih i hormonski zavisnih tumora dojke.” 2019. Thesis, Univerzitet u Beogradu. Accessed October 16, 2019. https://fedorabg.bg.ac.rs/fedora/get/o:19393/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Nedeljković, Milica D., 1984-. “Molekularno profilisanje i karakterizacija trostruko negativnih i hormonski zavisnih tumora dojke.” 2019. Web. 16 Oct 2019.

Vancouver:

Nedeljković, Milica D. 1. Molekularno profilisanje i karakterizacija trostruko negativnih i hormonski zavisnih tumora dojke. [Internet] [Thesis]. Univerzitet u Beogradu; 2019. [cited 2019 Oct 16]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:19393/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Nedeljković, Milica D. 1. Molekularno profilisanje i karakterizacija trostruko negativnih i hormonski zavisnih tumora dojke. [Thesis]. Univerzitet u Beogradu; 2019. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:19393/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. Scheib, Rachel L. Characterization of Cre Mouse Models to Target CNS Barriers for Generating Conditional Knockouts of ABC Transporters.

Degree: MS, Biomedical Sciences, 2014, University of Tennessee Health Science Center

 The central nervous system (CNS) includes the brain and spinal cord, where both possess a blood to brain and a blood to cerebrospinal fluid (CSF)… (more)

Subjects/Keywords: Pgp; BCRP; central nervous system; bloodbrain barrier; blood-CSF barrier; arachnoid; Medical Molecular Biology; Medical Sciences; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Scheib, R. L. (2014). Characterization of Cre Mouse Models to Target CNS Barriers for Generating Conditional Knockouts of ABC Transporters. (Thesis). University of Tennessee Health Science Center. Retrieved from https://dc.uthsc.edu/dissertations/235

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Scheib, Rachel L. “Characterization of Cre Mouse Models to Target CNS Barriers for Generating Conditional Knockouts of ABC Transporters.” 2014. Thesis, University of Tennessee Health Science Center. Accessed October 16, 2019. https://dc.uthsc.edu/dissertations/235.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Scheib, Rachel L. “Characterization of Cre Mouse Models to Target CNS Barriers for Generating Conditional Knockouts of ABC Transporters.” 2014. Web. 16 Oct 2019.

Vancouver:

Scheib RL. Characterization of Cre Mouse Models to Target CNS Barriers for Generating Conditional Knockouts of ABC Transporters. [Internet] [Thesis]. University of Tennessee Health Science Center; 2014. [cited 2019 Oct 16]. Available from: https://dc.uthsc.edu/dissertations/235.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Scheib RL. Characterization of Cre Mouse Models to Target CNS Barriers for Generating Conditional Knockouts of ABC Transporters. [Thesis]. University of Tennessee Health Science Center; 2014. Available from: https://dc.uthsc.edu/dissertations/235

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Houston

18. Jiang, Wen. Mechanisms of Interplay between UGTs and Efflux Transporters in Flavonoid Disposition.

Degree: Pharmacological and Pharmaceutical Sciences, Department of, University of Houston

 Objective: The overall objective is to investigate the mechanism(s) of interplay between UDP-glucuronosyltransferases (UGTs) and efflux transporters in flavonoid disposition. The goals of this research… (more)

Subjects/Keywords: HeLa cells; UGT1A9; BCRP; efflux transporter; flavonoid; disposition

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jiang, W. (n.d.). Mechanisms of Interplay between UGTs and Efflux Transporters in Flavonoid Disposition. (Thesis). University of Houston. Retrieved from http://hdl.handle.net/10657/2613

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jiang, Wen. “Mechanisms of Interplay between UGTs and Efflux Transporters in Flavonoid Disposition.” Thesis, University of Houston. Accessed October 16, 2019. http://hdl.handle.net/10657/2613.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jiang, Wen. “Mechanisms of Interplay between UGTs and Efflux Transporters in Flavonoid Disposition.” Web. 16 Oct 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Jiang W. Mechanisms of Interplay between UGTs and Efflux Transporters in Flavonoid Disposition. [Internet] [Thesis]. University of Houston; [cited 2019 Oct 16]. Available from: http://hdl.handle.net/10657/2613.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Jiang W. Mechanisms of Interplay between UGTs and Efflux Transporters in Flavonoid Disposition. [Thesis]. University of Houston; Available from: http://hdl.handle.net/10657/2613

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Toronto

19. Dedina, Liana. Riboflavin Transporters and Breast Cancer Resistance Protein: Cimetidine-Riboflavin Interactions in the Mammary Gland.

Degree: 2012, University of Toronto

Mother's milk provides multiple benefits to the offspring. However, xenobiotics transferred into breast milk may pose a risk to the nursing infant. The breast cancer… (more)

Subjects/Keywords: Pharmacology; Toxicology; Riboflavin; Cimetidine; Breast cancer resistance protein (BCRP); Riboflavin transporters; Breast milk; Mammary Gland; Lactation; 0419; 0383

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dedina, L. (2012). Riboflavin Transporters and Breast Cancer Resistance Protein: Cimetidine-Riboflavin Interactions in the Mammary Gland. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/33644

Chicago Manual of Style (16th Edition):

Dedina, Liana. “Riboflavin Transporters and Breast Cancer Resistance Protein: Cimetidine-Riboflavin Interactions in the Mammary Gland.” 2012. Masters Thesis, University of Toronto. Accessed October 16, 2019. http://hdl.handle.net/1807/33644.

MLA Handbook (7th Edition):

Dedina, Liana. “Riboflavin Transporters and Breast Cancer Resistance Protein: Cimetidine-Riboflavin Interactions in the Mammary Gland.” 2012. Web. 16 Oct 2019.

Vancouver:

Dedina L. Riboflavin Transporters and Breast Cancer Resistance Protein: Cimetidine-Riboflavin Interactions in the Mammary Gland. [Internet] [Masters thesis]. University of Toronto; 2012. [cited 2019 Oct 16]. Available from: http://hdl.handle.net/1807/33644.

Council of Science Editors:

Dedina L. Riboflavin Transporters and Breast Cancer Resistance Protein: Cimetidine-Riboflavin Interactions in the Mammary Gland. [Masters Thesis]. University of Toronto; 2012. Available from: http://hdl.handle.net/1807/33644


Freie Universität Berlin

20. Krühn, Andrea. Transkingdom RNAi: Modulation of the classical and atypical multidrug resistance by bacterial delivery of RNAi effectors.

Degree: 2013, Freie Universität Berlin

 RNA interference (RNAi) is a highly effective cellular mechanism of eucaryotic organisms that specifically inhibits gene expression. A major obstacle for the therapeutic application of… (more)

Subjects/Keywords: RNA interference; gene therapy; multidrug resistance; cancer; E. coli; ABCB1; MDR1; ABCG2; BCRP; 500 Naturwissenschaften und Mathematik::570 Biowissenschaften; Biologie

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Krühn, A. (2013). Transkingdom RNAi: Modulation of the classical and atypical multidrug resistance by bacterial delivery of RNAi effectors. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-8240

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Krühn, Andrea. “Transkingdom RNAi: Modulation of the classical and atypical multidrug resistance by bacterial delivery of RNAi effectors.” 2013. Thesis, Freie Universität Berlin. Accessed October 16, 2019. http://dx.doi.org/10.17169/refubium-8240.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Krühn, Andrea. “Transkingdom RNAi: Modulation of the classical and atypical multidrug resistance by bacterial delivery of RNAi effectors.” 2013. Web. 16 Oct 2019.

Vancouver:

Krühn A. Transkingdom RNAi: Modulation of the classical and atypical multidrug resistance by bacterial delivery of RNAi effectors. [Internet] [Thesis]. Freie Universität Berlin; 2013. [cited 2019 Oct 16]. Available from: http://dx.doi.org/10.17169/refubium-8240.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Krühn A. Transkingdom RNAi: Modulation of the classical and atypical multidrug resistance by bacterial delivery of RNAi effectors. [Thesis]. Freie Universität Berlin; 2013. Available from: http://dx.doi.org/10.17169/refubium-8240

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

21. Chedik, Lisa. Nature et conséquences des interactions entre transporteurs membranaires et pesticides : Nature and consequences of interactions between membrane transporters and pesticides.

Degree: Docteur es, Biologie et sciences de la santé, 2017, Rennes 1

Les pyréthrinoïdes et les organophosphorés sont des pesticides très utilisés, à l’origine d’une imprégnation forte de la population, exposée à ces contaminants principalement via l’alimentation.… (more)

Subjects/Keywords: Transporteurs membranaires; Transporteurs ABC; Transporteurs SLC; P-Gp; Bcrp; Mrp; Oatp; Oct; Oat; Mate; Pesticide; Pyréthrinoïdes; Composés organophosphorés; Qsar; Modélisation moléculaire; Membrane transporters; ABC transporters; SLC transporters; P-Gp; Bcrp; Mrp; Oatp; Oct; Oat; Mate; Pesticide; Pyrethroids; Organophosphorus compounds; Qsar; Docking

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chedik, L. (2017). Nature et conséquences des interactions entre transporteurs membranaires et pesticides : Nature and consequences of interactions between membrane transporters and pesticides. (Doctoral Dissertation). Rennes 1. Retrieved from http://www.theses.fr/2017REN1B035

Chicago Manual of Style (16th Edition):

Chedik, Lisa. “Nature et conséquences des interactions entre transporteurs membranaires et pesticides : Nature and consequences of interactions between membrane transporters and pesticides.” 2017. Doctoral Dissertation, Rennes 1. Accessed October 16, 2019. http://www.theses.fr/2017REN1B035.

MLA Handbook (7th Edition):

Chedik, Lisa. “Nature et conséquences des interactions entre transporteurs membranaires et pesticides : Nature and consequences of interactions between membrane transporters and pesticides.” 2017. Web. 16 Oct 2019.

Vancouver:

Chedik L. Nature et conséquences des interactions entre transporteurs membranaires et pesticides : Nature and consequences of interactions between membrane transporters and pesticides. [Internet] [Doctoral dissertation]. Rennes 1; 2017. [cited 2019 Oct 16]. Available from: http://www.theses.fr/2017REN1B035.

Council of Science Editors:

Chedik L. Nature et conséquences des interactions entre transporteurs membranaires et pesticides : Nature and consequences of interactions between membrane transporters and pesticides. [Doctoral Dissertation]. Rennes 1; 2017. Available from: http://www.theses.fr/2017REN1B035

22. Dufour, Robin. Différentes approches de l'optimisation du traitement du cancer du sein de phénotype "basal like" triple négatif par un anti-PARP : contournement des protéines "Multidrug Resistance" et traitement combiné radiothérapie / chimiothérapie. Spécialité : Different approaches for optimizing the treatment of breast cancer of the « basal like » triple negative phenotype by an anti-PARP : bypassing the "Multidrug Resistance" proteins and combined treatments by radiotherapy / chemotherapy.

Degree: Docteur es, Sciences de la vie et de la sante, 2016, Clermont-Ferrand 1

Le cancer du sein de phénotype « Basal-like » triple négatif (BLTN) est particulièrement agressif et de mauvais pronostic. Il est insensible aux traitements hormonaux… (more)

Subjects/Keywords: Cancer du sein Basal-like triple négatif,; Culture 3D; Radiothérapie à basse et haute énergie; Dosage intracellulaire d’Olaparib®,; BCRP; P-gp; Anti-PARP; « Triple Negative Basal-Like » breast cancer,; 3D cell culture; Low and high energy radiations; Intracellular level Olaparib®; Anti-PARP; BCRP,; P-gp,; 610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dufour, R. (2016). Différentes approches de l'optimisation du traitement du cancer du sein de phénotype "basal like" triple négatif par un anti-PARP : contournement des protéines "Multidrug Resistance" et traitement combiné radiothérapie / chimiothérapie. Spécialité : Different approaches for optimizing the treatment of breast cancer of the « basal like » triple negative phenotype by an anti-PARP : bypassing the "Multidrug Resistance" proteins and combined treatments by radiotherapy / chemotherapy. (Doctoral Dissertation). Clermont-Ferrand 1. Retrieved from http://www.theses.fr/2016CLF1MM05

Chicago Manual of Style (16th Edition):

Dufour, Robin. “Différentes approches de l'optimisation du traitement du cancer du sein de phénotype "basal like" triple négatif par un anti-PARP : contournement des protéines "Multidrug Resistance" et traitement combiné radiothérapie / chimiothérapie. Spécialité : Different approaches for optimizing the treatment of breast cancer of the « basal like » triple negative phenotype by an anti-PARP : bypassing the "Multidrug Resistance" proteins and combined treatments by radiotherapy / chemotherapy.” 2016. Doctoral Dissertation, Clermont-Ferrand 1. Accessed October 16, 2019. http://www.theses.fr/2016CLF1MM05.

MLA Handbook (7th Edition):

Dufour, Robin. “Différentes approches de l'optimisation du traitement du cancer du sein de phénotype "basal like" triple négatif par un anti-PARP : contournement des protéines "Multidrug Resistance" et traitement combiné radiothérapie / chimiothérapie. Spécialité : Different approaches for optimizing the treatment of breast cancer of the « basal like » triple negative phenotype by an anti-PARP : bypassing the "Multidrug Resistance" proteins and combined treatments by radiotherapy / chemotherapy.” 2016. Web. 16 Oct 2019.

Vancouver:

Dufour R. Différentes approches de l'optimisation du traitement du cancer du sein de phénotype "basal like" triple négatif par un anti-PARP : contournement des protéines "Multidrug Resistance" et traitement combiné radiothérapie / chimiothérapie. Spécialité : Different approaches for optimizing the treatment of breast cancer of the « basal like » triple negative phenotype by an anti-PARP : bypassing the "Multidrug Resistance" proteins and combined treatments by radiotherapy / chemotherapy. [Internet] [Doctoral dissertation]. Clermont-Ferrand 1; 2016. [cited 2019 Oct 16]. Available from: http://www.theses.fr/2016CLF1MM05.

Council of Science Editors:

Dufour R. Différentes approches de l'optimisation du traitement du cancer du sein de phénotype "basal like" triple négatif par un anti-PARP : contournement des protéines "Multidrug Resistance" et traitement combiné radiothérapie / chimiothérapie. Spécialité : Different approaches for optimizing the treatment of breast cancer of the « basal like » triple negative phenotype by an anti-PARP : bypassing the "Multidrug Resistance" proteins and combined treatments by radiotherapy / chemotherapy. [Doctoral Dissertation]. Clermont-Ferrand 1; 2016. Available from: http://www.theses.fr/2016CLF1MM05


Université Paris-Sud – Paris XI

23. Harati, Rania. Blood-Brain Barrier during cerebral maturation : impact of neuro-inflammation on the regulation of drug-efflux/influx transporters : Barrière Hémato-Encéphalique au cours de la Maturation Cérébrale : impact de la Neuro-Inflammation sur la Régulation des Transporteurs d’Efflux/Influx des Médicaments.

Degree: Docteur es, Pharmacologie - Toxicologie, 2012, Université Paris-Sud – Paris XI

L’échec thérapeutique des maladies cérébrales est lié, entre autres, à la présence de barrières entre le sang et le Système Nerveux Central (SNC), en particulier… (more)

Subjects/Keywords: BHE; Barrière hémato-encéphalique; Transporteurs ABC; Transporteurs SLC; P-gp; Bcrp; Oat3; Oatp1a4; Maturation cérébrale; Ontogenèse; Inflammation; Voie de signalisation Wnt/β-caténine; Endothéline-1; Blood-brain barrier; ABC transporters; Ontogenesis; P-gp; Bcrp; Oat3; Oatp1a4; Brain maturation; Inflammation; Endothelin-1; Wnt/β-catenin signaling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Harati, R. (2012). Blood-Brain Barrier during cerebral maturation : impact of neuro-inflammation on the regulation of drug-efflux/influx transporters : Barrière Hémato-Encéphalique au cours de la Maturation Cérébrale : impact de la Neuro-Inflammation sur la Régulation des Transporteurs d’Efflux/Influx des Médicaments. (Doctoral Dissertation). Université Paris-Sud – Paris XI. Retrieved from http://www.theses.fr/2012PA114856

Chicago Manual of Style (16th Edition):

Harati, Rania. “Blood-Brain Barrier during cerebral maturation : impact of neuro-inflammation on the regulation of drug-efflux/influx transporters : Barrière Hémato-Encéphalique au cours de la Maturation Cérébrale : impact de la Neuro-Inflammation sur la Régulation des Transporteurs d’Efflux/Influx des Médicaments.” 2012. Doctoral Dissertation, Université Paris-Sud – Paris XI. Accessed October 16, 2019. http://www.theses.fr/2012PA114856.

MLA Handbook (7th Edition):

Harati, Rania. “Blood-Brain Barrier during cerebral maturation : impact of neuro-inflammation on the regulation of drug-efflux/influx transporters : Barrière Hémato-Encéphalique au cours de la Maturation Cérébrale : impact de la Neuro-Inflammation sur la Régulation des Transporteurs d’Efflux/Influx des Médicaments.” 2012. Web. 16 Oct 2019.

Vancouver:

Harati R. Blood-Brain Barrier during cerebral maturation : impact of neuro-inflammation on the regulation of drug-efflux/influx transporters : Barrière Hémato-Encéphalique au cours de la Maturation Cérébrale : impact de la Neuro-Inflammation sur la Régulation des Transporteurs d’Efflux/Influx des Médicaments. [Internet] [Doctoral dissertation]. Université Paris-Sud – Paris XI; 2012. [cited 2019 Oct 16]. Available from: http://www.theses.fr/2012PA114856.

Council of Science Editors:

Harati R. Blood-Brain Barrier during cerebral maturation : impact of neuro-inflammation on the regulation of drug-efflux/influx transporters : Barrière Hémato-Encéphalique au cours de la Maturation Cérébrale : impact de la Neuro-Inflammation sur la Régulation des Transporteurs d’Efflux/Influx des Médicaments. [Doctoral Dissertation]. Université Paris-Sud – Paris XI; 2012. Available from: http://www.theses.fr/2012PA114856


Univerzitet u Beogradu

24. Kalinić, Marko D., 1988-. Simulacije milekularne dinamike i računarsko dizajniranje inhibitora protein lizin metiltransferaze EZH2.

Degree: Farmaceutski fakultet, 2016, Univerzitet u Beogradu

Farmacija - Farmaceutska–medicinska hemija i strukturna analiza / Pharmacy - Pharmaceutical–medicinal chemistry and structural analysis

Enhancer of Zeste Homolog 2 (EZH2) je epigenetski enzim koji… (more)

Subjects/Keywords: Enhancer of Zeste Homolog 2; epigenetics; anticancer drugs; molecular dynamics; de novo design; P-glycoprotein; breast cancer resistance protein; BCRP; computational classification models

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kalinić, Marko D., 1. (2016). Simulacije milekularne dinamike i računarsko dizajniranje inhibitora protein lizin metiltransferaze EZH2. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:10309/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kalinić, Marko D., 1988-. “Simulacije milekularne dinamike i računarsko dizajniranje inhibitora protein lizin metiltransferaze EZH2.” 2016. Thesis, Univerzitet u Beogradu. Accessed October 16, 2019. https://fedorabg.bg.ac.rs/fedora/get/o:10309/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kalinić, Marko D., 1988-. “Simulacije milekularne dinamike i računarsko dizajniranje inhibitora protein lizin metiltransferaze EZH2.” 2016. Web. 16 Oct 2019.

Vancouver:

Kalinić, Marko D. 1. Simulacije milekularne dinamike i računarsko dizajniranje inhibitora protein lizin metiltransferaze EZH2. [Internet] [Thesis]. Univerzitet u Beogradu; 2016. [cited 2019 Oct 16]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:10309/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kalinić, Marko D. 1. Simulacije milekularne dinamike i računarsko dizajniranje inhibitora protein lizin metiltransferaze EZH2. [Thesis]. Univerzitet u Beogradu; 2016. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:10309/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Swedish University of Agricultural Sciences

25. Tydén, Eva. Cytochrome P450 3A and ABC-transport proteins in horse.

Degree: 2008, Swedish University of Agricultural Sciences

 In this thesis cytochrome P450 3A (CYP3A) and the ABC-transport proteins P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), multidrug resistance protein 1 (MRP1) and multidrug… (more)

Subjects/Keywords: horse; chytochrome p450; binding proteins; metabolism; intestines; kidney; liver; lungs; lymphocytes; gene expression; horse; CYP3a; P-gp; BCRP; MRP1; MRP2; intestine; liver; kidney; upper respiratory airways; lymphocytes; brunner´s glands

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tydén, E. (2008). Cytochrome P450 3A and ABC-transport proteins in horse. (Doctoral Dissertation). Swedish University of Agricultural Sciences. Retrieved from http://pub.epsilon.slu.se/1900/

Chicago Manual of Style (16th Edition):

Tydén, Eva. “Cytochrome P450 3A and ABC-transport proteins in horse.” 2008. Doctoral Dissertation, Swedish University of Agricultural Sciences. Accessed October 16, 2019. http://pub.epsilon.slu.se/1900/.

MLA Handbook (7th Edition):

Tydén, Eva. “Cytochrome P450 3A and ABC-transport proteins in horse.” 2008. Web. 16 Oct 2019.

Vancouver:

Tydén E. Cytochrome P450 3A and ABC-transport proteins in horse. [Internet] [Doctoral dissertation]. Swedish University of Agricultural Sciences; 2008. [cited 2019 Oct 16]. Available from: http://pub.epsilon.slu.se/1900/.

Council of Science Editors:

Tydén E. Cytochrome P450 3A and ABC-transport proteins in horse. [Doctoral Dissertation]. Swedish University of Agricultural Sciences; 2008. Available from: http://pub.epsilon.slu.se/1900/


University of Manchester

26. Georgiou, Leonidas. DCE-MRI assessment of hepatic uptake and efflux of the contrast agent, gadoxetate, to monitor transporter-mediated processes and drug-drug interactions: in vitro and in vivo studies.

Degree: 2015, University of Manchester

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) techniques offer the opportunity to understand the physiological processes involved in the distribution of the contrast agent in vivo.… (more)

Subjects/Keywords: Gadoxetate; Tracer Kinetic Model; Pharmacokinetics; Hepatobiliary; Primovist; DCE-MRI; In vivo; In vitro; OATP; Pgp; BCRP; Clinical; Preclinical; LC-MS/MS; Liver Function; Uptake; Efflux; Contrast Agents; Drug drug interactions

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Georgiou, L. (2015). DCE-MRI assessment of hepatic uptake and efflux of the contrast agent, gadoxetate, to monitor transporter-mediated processes and drug-drug interactions: in vitro and in vivo studies. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:260124

Chicago Manual of Style (16th Edition):

Georgiou, Leonidas. “DCE-MRI assessment of hepatic uptake and efflux of the contrast agent, gadoxetate, to monitor transporter-mediated processes and drug-drug interactions: in vitro and in vivo studies.” 2015. Doctoral Dissertation, University of Manchester. Accessed October 16, 2019. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:260124.

MLA Handbook (7th Edition):

Georgiou, Leonidas. “DCE-MRI assessment of hepatic uptake and efflux of the contrast agent, gadoxetate, to monitor transporter-mediated processes and drug-drug interactions: in vitro and in vivo studies.” 2015. Web. 16 Oct 2019.

Vancouver:

Georgiou L. DCE-MRI assessment of hepatic uptake and efflux of the contrast agent, gadoxetate, to monitor transporter-mediated processes and drug-drug interactions: in vitro and in vivo studies. [Internet] [Doctoral dissertation]. University of Manchester; 2015. [cited 2019 Oct 16]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:260124.

Council of Science Editors:

Georgiou L. DCE-MRI assessment of hepatic uptake and efflux of the contrast agent, gadoxetate, to monitor transporter-mediated processes and drug-drug interactions: in vitro and in vivo studies. [Doctoral Dissertation]. University of Manchester; 2015. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:260124

27. Zhang, Fan. Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a.

Degree: PhD, Pharmaceutical Sciences, 2011, University of Tennessee Health Science Center

  Nutlin-3a is an MDM2-p53 interaction antagonist that is under investigation in preclinical models for a variety of pediatric malignancies, including neuroblastoma, retinoblastoma, leukemia, and… (more)

Subjects/Keywords: ABC transporter; BCRP; Nutlin-3a; Pharmacokinetics; PBPK; Medicinal and Pharmaceutical Chemistry; Medicine and Health Sciences; Pharmaceutics and Drug Design; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, F. (2011). Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a. (Doctoral Dissertation). University of Tennessee Health Science Center. Retrieved from https://dc.uthsc.edu/dissertations/312

Chicago Manual of Style (16th Edition):

Zhang, Fan. “Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a.” 2011. Doctoral Dissertation, University of Tennessee Health Science Center. Accessed October 16, 2019. https://dc.uthsc.edu/dissertations/312.

MLA Handbook (7th Edition):

Zhang, Fan. “Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a.” 2011. Web. 16 Oct 2019.

Vancouver:

Zhang F. Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a. [Internet] [Doctoral dissertation]. University of Tennessee Health Science Center; 2011. [cited 2019 Oct 16]. Available from: https://dc.uthsc.edu/dissertations/312.

Council of Science Editors:

Zhang F. Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a. [Doctoral Dissertation]. University of Tennessee Health Science Center; 2011. Available from: https://dc.uthsc.edu/dissertations/312


Vrije Universiteit Amsterdam

28. Oerlemans, R. Molecular mechanisms of resistance to classical and experimental anti-rheumatic drugs .

Degree: 2010, Vrije Universiteit Amsterdam

Subjects/Keywords: Rheumatoid Arthritis DMARDs Methotrexate resistance ABC transporters bortezomib MRP1 BCRP PGP

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oerlemans, R. (2010). Molecular mechanisms of resistance to classical and experimental anti-rheumatic drugs . (Doctoral Dissertation). Vrije Universiteit Amsterdam. Retrieved from http://hdl.handle.net/1871/15948

Chicago Manual of Style (16th Edition):

Oerlemans, R. “Molecular mechanisms of resistance to classical and experimental anti-rheumatic drugs .” 2010. Doctoral Dissertation, Vrije Universiteit Amsterdam. Accessed October 16, 2019. http://hdl.handle.net/1871/15948.

MLA Handbook (7th Edition):

Oerlemans, R. “Molecular mechanisms of resistance to classical and experimental anti-rheumatic drugs .” 2010. Web. 16 Oct 2019.

Vancouver:

Oerlemans R. Molecular mechanisms of resistance to classical and experimental anti-rheumatic drugs . [Internet] [Doctoral dissertation]. Vrije Universiteit Amsterdam; 2010. [cited 2019 Oct 16]. Available from: http://hdl.handle.net/1871/15948.

Council of Science Editors:

Oerlemans R. Molecular mechanisms of resistance to classical and experimental anti-rheumatic drugs . [Doctoral Dissertation]. Vrije Universiteit Amsterdam; 2010. Available from: http://hdl.handle.net/1871/15948

29. LIU XIAOLING. Basic Chalcones: Design, synthesis and evaluation of antiproliferative and other properties.

Degree: 2008, National University of Singapore

Subjects/Keywords: basic chalcones; antiproliferative activity; Pgp and BCRP inhibitors; cell cycle; antibacterial activity; SAR

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

XIAOLING, L. (2008). Basic Chalcones: Design, synthesis and evaluation of antiproliferative and other properties. (Thesis). National University of Singapore. Retrieved from http://scholarbank.nus.edu.sg/handle/10635/13272

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

XIAOLING, LIU. “Basic Chalcones: Design, synthesis and evaluation of antiproliferative and other properties.” 2008. Thesis, National University of Singapore. Accessed October 16, 2019. http://scholarbank.nus.edu.sg/handle/10635/13272.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

XIAOLING, LIU. “Basic Chalcones: Design, synthesis and evaluation of antiproliferative and other properties.” 2008. Web. 16 Oct 2019.

Vancouver:

XIAOLING L. Basic Chalcones: Design, synthesis and evaluation of antiproliferative and other properties. [Internet] [Thesis]. National University of Singapore; 2008. [cited 2019 Oct 16]. Available from: http://scholarbank.nus.edu.sg/handle/10635/13272.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

XIAOLING L. Basic Chalcones: Design, synthesis and evaluation of antiproliferative and other properties. [Thesis]. National University of Singapore; 2008. Available from: http://scholarbank.nus.edu.sg/handle/10635/13272

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Helsinki

30. Lipponen, Lotta-Maaria. Literature review: BCRP- and BSEP-mediated drug interactions from the perspective of clinical significance.

Degree: Farmaceutiska fakulteten, 2015, University of Helsinki

Subjects/Keywords: BCRP; BSEP; CDCF; clinical significance; vesicular transport assay; lucifer yellow; kliininen merkittävyys; vesikkelikoe; Biofarmaci; Biopharmacy; Biofarmasia; BCRP; BSEP; CDCF; clinical significance; vesicular transport assay; lucifer yellow; kliininen merkittävyys; vesikkelikoe

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lipponen, L. (2015). Literature review: BCRP- and BSEP-mediated drug interactions from the perspective of clinical significance. (Masters Thesis). University of Helsinki. Retrieved from http://hdl.handle.net/10138/152778

Chicago Manual of Style (16th Edition):

Lipponen, Lotta-Maaria. “Literature review: BCRP- and BSEP-mediated drug interactions from the perspective of clinical significance.” 2015. Masters Thesis, University of Helsinki. Accessed October 16, 2019. http://hdl.handle.net/10138/152778.

MLA Handbook (7th Edition):

Lipponen, Lotta-Maaria. “Literature review: BCRP- and BSEP-mediated drug interactions from the perspective of clinical significance.” 2015. Web. 16 Oct 2019.

Vancouver:

Lipponen L. Literature review: BCRP- and BSEP-mediated drug interactions from the perspective of clinical significance. [Internet] [Masters thesis]. University of Helsinki; 2015. [cited 2019 Oct 16]. Available from: http://hdl.handle.net/10138/152778.

Council of Science Editors:

Lipponen L. Literature review: BCRP- and BSEP-mediated drug interactions from the perspective of clinical significance. [Masters Thesis]. University of Helsinki; 2015. Available from: http://hdl.handle.net/10138/152778

[1] [2]

.